Postoperative adhesion remains one of the most common and challenging complications following abdominal and pelvic surgery. Studies report that the incidence of intra-abdominal adhesions can reach up to 90% after major abdominal procedures, leading to intestinal obstruction, chronic pelvic pain, infertility, and increased risk during repeat surgeries. As surgical volumes continue to rise globally, effective adhesion prevention strategies have become a critical focus for surgeons, hospitals, and medical distributors alike.
Among currently available anti-adhesion solutions, adhesion barrier gel based on sodium hyaluronate has emerged as one of the most clinically validated and widely adopted approaches.
Why Adhesion Prevention Matters in Clinical Outcomes
Postoperative adhesions are not merely anatomical abnormalities; they directly affect patient recovery and healthcare costs. Adhesions can:
Prolong postoperative bowel recovery
Increase postoperative inflammation and pain
Lead to secondary surgeries with higher operative risks
Increase long-term healthcare expenditure
From both a clinical and economic perspective, adhesion prevention is increasingly regarded as a standard component of high-quality surgical care rather than an optional adjunct.
Sodium Hyaluronate Adhesion Barrier Gel: Clinical Evidence
A large-scale randomized clinical study involving 521 patients undergoing abdominal and pelvic surgery evaluated the effectiveness and safety of medical sodium hyaluronate gel for adhesion prevention. In this study, patients were divided into a sodium hyaluronate gel group and a control group without any anti-adhesion material.
Key Clinical Findings
The results clearly demonstrated significant advantages in the sodium hyaluronate adhesion barrier gel group:
Earlier return of bowel function
Mean time to first flatus and bowel movement was 19.8 ± 1.7 hours, compared with 37.1 ± 3.6 hours in the control group.
Reduced postoperative inflammation
Elevated white blood cell counts occurred in only 8.0% of patients in the gel group versus 40.7% in the control group.
Lower incidence of postoperative pain and discomfort
Postoperative pain and discomfort were reported in 6.8% of patients using the gel, compared with 24.0% in patients without adhesion prevention.
Significantly reduced adhesion formation
Postoperative adhesions occurred in 16 cases in the gel group, versus 94 cases in the control group, with both primary and recurrent adhesions markedly reduced
These findings confirm that sodium hyaluronate adhesion barrier gel not only reduces adhesion rates but also improves overall postoperative recovery quality.
Mechanism of Action: How Adhesion Barrier Gel Works
The effectiveness of sodium hyaluronate–based adhesion barrier gel is rooted in its multi-layered biological mechanisms:
Physical Barrier Formation
The gel forms a temporary viscoelastic coating over injured tissues, preventing direct contact between adjacent organs during the critical healing window.
Inhibition of Fibroblast Activity
By reducing fibroblast proliferation and fibrin deposition, the gel limits the structural foundation of adhesion formation.
Anti-inflammatory Properties
High-molecular-weight sodium hyaluronate suppresses leukocyte migration and inflammatory responses, reducing postoperative tissue irritation.
Promotion of Tissue Repair
As a natural component of the extracellular matrix, sodium hyaluronate supports mesothelial regeneration and physiological healing.
These combined effects make adhesion barrier gel particularly effective during the first 7 days post-surgery, the most critical period for adhesion development.
Singclean Adhesion Barrier Gel: Product Advantages
Building upon the proven clinical value of sodium hyaluronate, Singclean Adhesion Barrier Gel is designed to meet modern surgical and procurement demands.
Key Product Highlights
Medical-grade sodium hyaluronate formulation with excellent biocompatibility
Stable gel consistency for precise application on surgical sites
Effective coverage of irregular tissue surfaces, ensuring uniform barrier formation
Absorbable and biodegradable, eliminating the need for removal
Manufactured under strict quality control systems, supporting international distribution and regulatory compliance
Value for Distributors and Clinics
For medical distributors, adhesion barrier gel represents a product category with:
Strong clinical demand
Clear differentiation supported by evidence-based medicine
Broad application across general surgery, gynecology, and minimally invasive procedures
For clinics and hospitals, adopting a reliable adhesion barrier gel contributes to:
Improved patient outcomes
Reduced postoperative complications
Enhanced surgical quality metrics
Conclusion
Clinical evidence strongly supports sodium hyaluronate–based adhesion barrier gel as a safe and effective solution for preventing postoperative adhesions in abdominal and pelvic surgery. With its proven mechanisms, strong safety profile, and tangible impact on recovery outcomes, adhesion barrier gel is becoming an integral component of modern surgical protocols.
Singclean Adhesion Barrier Gel combines validated science with manufacturing reliability, offering a practical and scalable solution for global healthcare partners.
Reference: Clinical effectiveness of medical sodium hyaluronate gel in preventing postoperative adhesion after abdominal and pelvic surgery. Chinese Journal of General Practice. 2015;13(4):579–585.